Two Of Aurobindo’s Europe Biosimilar Filings Stuck, Licenses Ryzneuta From Yifan Pharma

Could MHRA Approve Bevacizumab Biosimilar Minus Phase III Trial?

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.